2000
DOI: 10.1006/bbrc.2000.3706
|View full text |Cite
|
Sign up to set email alerts
|

Cytochrome P4503A-Dependent Metabolism of Tocopherols and Inhibition by Sesamin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
139
2
2

Year Published

2002
2002
2010
2010

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 195 publications
(149 citation statements)
references
References 21 publications
6
139
2
2
Order By: Relevance
“…It has been reported that the intake of sesame seeds and sesame lignan can cause a marked increase of the a-tocopherol concentration in the blood and tissues of rats (Yamashita et al, 1995), and that sesamin inhibits the metabolism of tocopherol to CEHC by HepG2=C3A cells (Parker et al, 2000). Parker also studied the metabolism of tocopherol to CEHC by cultured cells and the inhibition of its metabolism by ketoconozole, and suggested that cytochrome P4503A might be involved in vitamin E metabolism (Parker et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that the intake of sesame seeds and sesame lignan can cause a marked increase of the a-tocopherol concentration in the blood and tissues of rats (Yamashita et al, 1995), and that sesamin inhibits the metabolism of tocopherol to CEHC by HepG2=C3A cells (Parker et al, 2000). Parker also studied the metabolism of tocopherol to CEHC by cultured cells and the inhibition of its metabolism by ketoconozole, and suggested that cytochrome P4503A might be involved in vitamin E metabolism (Parker et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, in wild-type fetuses, low-dose VE consistently failed to increase a-tocopherol levels in any tissue, which accounts for the absence of any reduction in oxidative DNA damage in þ/þ p53 fetuses. The mechanisms underlying this differential VE disposition in wild-type fetuses are not clear; but, as for the tissue-selective differences, these may include variations in membrane transporters 37,38 and, at least in the liver, metabolism of a-tocopherol by the cytochromes P450 CYP3A4 and CYP4F2, 39,40 which may be expressed the fetus towards the end of gestation. 41,42 The tissue-and p53 genotype-dependent nature of the antioxidative efficacy of low-dose VE may explain, in part, the conflicting published reports of antitumor efficacy of VE for different cancers.…”
Section: In Utero Origins Of Cancer/chen Et Almentioning
confidence: 99%
“…CYP3A has ω-hydroxylase activity and was first reported to be involved in vitamin E metabolism because of changes in levels of CEHC metabolites in HepG2 cells when a CYP inhibitor, ketoconazole (KCZ), or a CYP inducer, rifampicin, was added to the medium [12,13]. In the present study, despite a significant induction of CYP3A protein in both OFO-treated groups, the excretion of α-CEHC in the urine was not significantly increased in the OFE group compared to the CO group.…”
Section: Discussionmentioning
confidence: 99%
“…First, levels of the metabolite product of α-tocopherol in the urine, α-carboxyethyl hydroxychroman (α-CEHC) [11], might be increased if α-tocopherol catabolism in liver were enhanced. α-CEHC is reported to be produced by cytochrome P450 3A (CYP3A), the xenobiotic metabolizing enzyme [12,13]. Second, since α-tocopherol can be excreted in the feces with bile [14], the higher levels of radiolabeled α-tocopherol in the feces could come from increased bile excretion.…”
Section: Introductionmentioning
confidence: 99%